Eve Health Group Ltd

$0.016

Day Range

$0.016 – $0.016

Volume

0.00

Avg Volume (10D)

191.96K

Market Cap

$5.64M

Price Chart

Market Statistics

Open$0.016

Previous Close$0.016

Day High$0.016

Day Low$0.016

Valuation

Market Cap5.64M

Shares Outstanding352.33M

Price to Book1.21

Trading Activity

Volume0.00

Value Traded0.00

Bid$0.015 × 200,000

Ask$0.017 × 339,555

Performance

1 Day0.00%

5 Day0.00%

13 Week-40.74%

52 Week-51.52%

YTD-23.81%

EVE Health Group Initiates Pilot Study of Libbo Oral Soluble Film to Treat ED

EVE Health launches pilot Libbo ED study (oral soluble film), a key bioequivalence step toward regulatory approval; results expected by end-September. ASX:EVE

By Imelda Cotton··1 min read min read

Biotechnology

EVE Health Appoints New CEO to Lead Company Through Next Phase of Growth

EVE Health appoints COO Ben Rohr as new CEO to drive next growth phase and accelerate commercialisation; Damian Wood shifts to regulatory/medical affairs.

By Imelda Cotton··1 min read min read

Biotechnology

EVE Health Increases Capital Raising to $1.3m with $400,000 Cornerstone Investment

EVE Health Group lifts capital raise to $1.3m with $400k cornerstone, signalling reformulated-drug strategy and new science adviser amid Libbo launch.

By Imelda Cotton··1 min read min read

Biotechnology

EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline

EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.

By Nik Hill··1 min read min read